Notification of Dr. Bernard grosse Broermann according to section 43 para 1 WpHG

Dr. Bernard grosse Broermann refers to his notification concerning RHÖN-KLINIKUM Aktiengesellschaft ('Corporation') of 2 January 2018 in connection with meeting the threshold based on a reorganization on level of a subsidiary.

With respect to the objectives pursued with the acquisition of the voting rights, Dr. Bernard grosse Broermann has informed us according to sections 43 para 1 sentence 1 and 3 and section 37 of the German Securities Trading Act, that he:

1. considers the holding in the corporation as a long-term strategic investment.

2. is eventually willing to obtain further voting rights by acquisition or any other way within the next 12 months - depending on the share price and the general performance of the corporation.

3. intends to obtain an appropriate representation on the supervisory board and intends to execute his voting rights accordingly.

4. does not intend to essentially change the capital structure of the corporation, especially with regards to the ratio of internal/outside funding and the dividend policy.

Moreover Dr. Bernard grosse Broermann has informed us according to section 43 para 1 sentence 1 and 4 of the German Securities Trading Act with respect to the origin of the used funds for the acquisition of the voting rights, that:

The obligation for this notification was merely caused by the meeting of the threshold based on reorganization on level of a subsidiary. Hence neither internal nor outside funding was used for acquisition of voting rights.
 

Bad Neustadt a. d. Saale, 26 January 2018
 

Kai Knitter
Head of Corporate Communications and Investor Relations
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Phone: +49 9771 65 - 1328
Fax: +49 9771 99 - 1736